1. Home
  2. CNSP vs FTEL Comparison

CNSP vs FTEL Comparison

Compare CNSP & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CNS Pharmaceuticals Inc.

CNSP

CNS Pharmaceuticals Inc.

HOLD

Current Price

$6.09

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Logo Fitell Corporation

FTEL

Fitell Corporation

HOLD

Current Price

$3.52

Market Cap

3.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNSP
FTEL
Founded
2017
2007
Country
United States
Australia
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8M
3.7M
IPO Year
2019
2023

Fundamental Metrics

Financial Performance
Metric
CNSP
FTEL
Price
$6.09
$3.52
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$20.00
N/A
AVG Volume (30 Days)
73.0K
425.2K
Earning Date
11-17-2025
11-17-2025
Dividend Yield
N/A
45.45%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,200,138.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.42
52 Week Low
$4.93
$2.91
52 Week High
$114.00
$1,427.20

Technical Indicators

Market Signals
Indicator
CNSP
FTEL
Relative Strength Index (RSI) 45.58 73.05
Support Level $5.75 $2.96
Resistance Level $7.51 $3.50
Average True Range (ATR) 0.72 0.28
MACD 0.09 0.14
Stochastic Oscillator 22.58 90.39

Price Performance

Historical Comparison
CNSP
FTEL

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

About FTEL Fitell Corporation

Fitell Corp conducts its primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiary, serving personal training studios and commercial gyms. Its product coverage includes four proprietary brands: Muscle Motion for strength-training equipment, Rapid Motion with a focus on commercial items, FleetX for cardio equipment, and Harison for cardio, strength, recovery, and conditioning products. The Company operates in one segment, trading gym equipment, and also provides licensing services and gym equipment to overseas gym studios. Majority of its business is conducted in Australia via its e-commerce platform and third-party sites, with maximum revenue earned from retail.

Share on Social Networks: